Literature DB >> 17559902

Interferons induce an antiviral state in human pancreatic islet cells.

Monica Hultcrantz1, Michael H Hühn, Monika Wolf, Annika Olsson, Stella Jacobson, Bryan R Williams, Olle Korsgren, Malin Flodström-Tullberg.   

Abstract

Enterovirus infections, in particular those with Coxsackieviruses, have been linked to the development of type 1 diabetes (T1D). Although animal models have demonstrated that interferons (IFNs) regulate virus-induced T1D by acting directly on the beta cell, little is known on the human pancreatic islet response to IFNs. Here we show that human islet cells respond to IFNs by expressing signature genes of antiviral defense. We also demonstrate that they express three intracellular sensors for viral RNA, the toll like receptor 3 (TLR3) gene, the retinoic acid-inducible gene I (RIG-I) and the melanoma differentiation-associated gene-5 (MDA-5), which induce type I IFN production in infected cells. Finally, we show for the first time that the IFN-induced antiviral state provides human islets with a powerful protection from the replication of Coxsackievirus. This may be critical for beta cell survival and protection from virus-induced T1D in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559902     DOI: 10.1016/j.virol.2007.05.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

Review 1.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.

Authors:  K Lind; M H Hühn; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 2.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

3.  MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.

Authors:  Jennifer P Wang; Anna Cerny; Damon R Asher; Evelyn A Kurt-Jones; Roderick T Bronson; Robert W Finberg
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 4.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 5.  Targeting Innate Immunity for Type 1 Diabetes Prevention.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

6.  Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Authors:  K Lind; E Svedin; R Utorova; V M Stone; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

Review 8.  Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

9.  MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA.

Authors:  Maikel L Colli; Fabrice Moore; Esteban N Gurzov; Fernanda Ortis; Decio L Eizirik
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

10.  Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Authors:  Shoichiro Tanaka; Yoriko Nishida; Kaoru Aida; Taro Maruyama; Akira Shimada; Masako Suzuki; Hiroki Shimura; Soichi Takizawa; Masashi Takahashi; Daiichiro Akiyama; Sayaka Arai-Yamashita; Fumihiko Furuya; Akio Kawaguchi; Masahiro Kaneshige; Ryohei Katoh; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2009-07-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.